‘Ischemia subgroup’ | ‘Necrosis subgroup’ | ‘Ischemia associated necrosis subgroup’ | ||||
---|---|---|---|---|---|---|
Mean ± SD | 95% CI | Mean ± SD | 95% CI | Mean ± SD | 95% CI | |
Patients (n) | 17 | 67 | 16 | |||
SSRSa | 9.9 ± 6.7 | [13.0–6.8] | 13.3 ± 6.1 | [13.1–13.4] | 13.8 ± 5.8 | [13.5–14.1] |
SSRSb | 9.9 ± 6.4 | [12.9–7.0] | 13.2 ± 6.0 | [13.1–13.3] | 13.6 ± 5.4 | [13.7–14.3] |
SSRSwsa | 8.1 ± 6.3 | [11.0–5.1] | 11.1 ± 5.7 | [10.9–11.2] | 12.1 ± 5.7 | [11.8–12.4] |
SSRSwsb | 8.3 ± 6.3 | [11.2–5.4] | 10.8 ± 5.6 | [10.7–10.9] | 11.8 ± 5.5 | [11.5–12.0] |
∆ | − 0.1 ± 0.9 | [− 0.5 to 0.4] | 0.1 ± 1.2 | [0.0–0.1] | 0.3 ± 1.2 | [0.2–0.3] |
∆r (%) | − 1.6 ± 11.9 | [− 7.1 to 3.9] | − 0.5 ± 11.5 | [− 0.8 to − 0.2] | 0.7 ± 8.5 | [0.3–1.2] |
∆ws | − 0.2 ± 1.0 | [− 0.7 to 0.2] | 0.3 ± 0.9 | [0.2–0.3] | 0.3 ± 1.2 | [0.3–0.4] |
∆rws (%) | − 3.6 ± 15.9 | [− 10.9 to 3.7] | 2.1 ± 8.4 | [1.9–2.3] | 3.2 ± 8.8 | [2.8–3.7] |
SSRSa/SSRSb | P = 0.79 | P = 0.67 | P = 0.43 |